360head Stockiq
Global Intelligence Terminal
Loading live prices…
LIVE
--:--:--
AI-generated, informational and educational only. Not financial advice. Past performance does not indicate future results. Always do your own research.

Regeneron Pharmaceuticals Inc (REGN)

A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.

Biotechnology· US· www.regeneron.com
Trade REGN on Webull →
46/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)56%

Also measured against its sector ETF (XBI).

Our last 30 days of resolved calls came true 18% of the time.See the track record →

Price
$955.47
1 day
+0.45%
1 week
+5.18%
Month to date
+2.51%
1 year
+39.53%
Market cap
$98.8B
Company fundamentals
P/E (TTM)
20.5×
EPS (TTM)
$45.28
Debt / Equity
0.08
Current ratio
3.35
Operating margin
28.8%
Net margin
28.5%
Gross margin
86.8%
Return on equity
15.1%
Revenue growth (YoY)
18.6%
Dividend yield
0.39%

Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.

Example trade plan · illustrative risk framework
Entry zone
$941.14–$974.58
Stop-loss (exit)
$859.92 −10%
Target (exit)
$1,146.56 +20%

A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.

Why it ranks: factor attribution

Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →

Why it's moving: recent catalysts

🤖 The dominant catalyst is product (positive clinical data for Regeneron's heart-rate drug), with the dividend and valuation headlines acting as secondary context rather than a fundamental driver. Continuation likelihood over the next few weeks is moderate (~40–50%), since single-study readouts often fade without confirmatory data or regulatory milestones. Informational only — not financial advice.

Any AI summary is an interpretation of public news, not advice or a price target.

REGN Signal Score & analysis · 360head Stockiq